Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-05-07, Stock:LLY, The news for the past five days is as follows:
2020-04-30: NEWS1: Amgen Stock Jumps on Earnings, Covid-19 Trial Announcement.NEWS2: Lilly to Participate in Bank of America Securities Health Care Conference.NEWS3: Los Angeles makes coronavirus testing available.NEWS4: Hologic (HOLX) Beats Q2 Earnings Estimates, Withdraws View.
2020-05-01: NEWS1: Illumina (ILMN) Beats Q1 Earnings Estimates, Withdraws View.NEWS2: 3 Bullish Coronavirus Stocks to Trade Into Weakness.
2020-05-04: NEWS1: Lilly Declares Second-Quarter 2020 Dividend.NEWS2: Drugmaker Eli Lilly Partners With China’s Junshi For Covid-19 Antibody Treatment.NEWS3: Were Hedge Funds Right About Eli Lilly and Company (LLY)?.NEWS4: Hill-Rom's (HRC) Q2 Earnings Top Estimates, Margins Expand.NEWS5: Teleflex (TFX) Earnings and Revenues Beat Estimates in Q1.NEWS6: Syneos Health (SYNH) Tops Q1 Earnings Estimates, Margins Down.NEWS7: Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19.NEWS8: Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19.
2020-05-05: NEWS1: The Vanguard Health Care Fund Exits CVS Health, Teva Pharmaceutical.NEWS2: Lilly to Participate in UBS Virtual Global Healthcare Conference.NEWS3: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS4: Incyte (INCY) Misses Q1 Earnings Estimates, Beats on Revenues.NEWS5: Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates.NEWS6: Tandem Diabetes (TNDM) Q1 Loss Widens, Revenues Top Estimates.
2020-05-06: NEWS1: Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer.NEWS2: Myriad Genetics (MYGN) Lags Q3 Earnings Estimates, Cancels View.NEWS3: CVS Health (CVS) Q1 Earnings Top Estimates, Costs Escalate.NEWS4: Jazz Pharma (JAZZ) Misses on Q1 Earnings & Sales, Cuts View.NEWS5: Haemonetics (HAE) Q4 Earnings Lag Estimates, Margins Expand.NEWS6: Inogen's (INGN) Q1 Earnings and Revenues Beat Estimates.NEWS7: DaVita (DVA) Earnings and Revenues Beat Estimates in Q1.NEWS8: After Its Strong First-Quarter Results, Should You Buy Shares of Eli Lilly?.NEWS9: PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates.NEWS10: Why These 8 Pharma Stocks Are Outplaying 90% Of The Stock Market.

Answer: Decrease